• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Chin J Acad Radiol . Coronary artery calcification and risk of mortality and adverse outcomes in patients with COVID-19: a Chinese multicenter retro

tetano

Editor, Senior Moderator
Chin J Acad Radiol


. 2021 Jun 28;1-9.
doi: 10.1007/s42058-021-00072-4. Online ahead of print.
Coronary artery calcification and risk of mortality and adverse outcomes in patients with COVID-19: a Chinese multicenter retrospective cohort study


Song Luo[SUP] #[/SUP][SUP] 1 [/SUP], Xiao Ming Qiu[SUP] #[/SUP][SUP] 2 [/SUP], Xian Jun Zeng[SUP] 3 [/SUP], Dong You Zhang[SUP] #[/SUP][SUP] 4 [/SUP], Bing Wan[SUP] 5 [/SUP], Xiao Li[SUP] 1 6 [/SUP], Rong Hua Tian[SUP] 7 [/SUP], Jiang Tao Wang[SUP] 8 [/SUP], Mei Yun Wang[SUP] 9 [/SUP], Juan Zhu[SUP] 10 [/SUP], Can Zhang[SUP] 11 [/SUP], Ran Yang[SUP] 12 [/SUP], Feng Chen[SUP] 13 [/SUP], Yi Liang[SUP] 14 [/SUP], Bin Fan[SUP] 15 [/SUP], Hui Jie Jiang[SUP] 16 [/SUP], Xi Ming Wang[SUP] 17 [/SUP], Wei Chen[SUP] 18 [/SUP], Kai Xu[SUP] 19 [/SUP], Jian Bo Gao[SUP] 20 [/SUP], Chao Du[SUP] 21 [/SUP], Li Na Zhang[SUP] 22 [/SUP], Yi Yang[SUP] 4 [/SUP], Shi Jun Jia[SUP] 8 [/SUP], Hao Ren[SUP] 8 [/SUP], Zi Yue Zu[SUP] 1 [/SUP], Peng Peng Xu[SUP] 1 [/SUP], Jing Zhong[SUP] 1 [/SUP], Yu Ting Yang[SUP] 1 [/SUP], Chang Sheng Zhou[SUP] 1 [/SUP], Wei Zhang[SUP] 1 [/SUP], Xiao Xue Liu[SUP] 1 [/SUP], Qi Rui Zhang[SUP] 1 [/SUP], Fei Xia[SUP] 1 [/SUP], Li Qi[SUP] 1 [/SUP], Meng Jie Lu[SUP] 1 [/SUP], Long Jiang Zhang[SUP] 1 [/SUP], Yu Xiu Liu[SUP] 23 [/SUP], Guang Ming Lu[SUP] 1 [/SUP]



Affiliations

Abstract

Background: Coronary artery calcification (CAC) is an independent risk factor of major adverse cardiovascular events; however, the impact of CAC on in-hospital death and adverse clinical outcomes in patients with coronavirus disease 2019 (COVID-19) remains unclear.
Objective: To explore the association between CAC and in-hospital mortality and adverse events in patients with COVID-19.
Methods: This multicenter retrospective cohort study enrolled 2067 laboratory-confirmed COVID-19 patients with definitive clinical outcomes (death or discharge) admitted from 22 tertiary hospitals in China between January 3, 2020 and April 2, 2020. Demographic, clinical, laboratory results, chest CT findings, and CAC on admission were collected. The primary outcome was in-hospital death and the secondary outcome was composed of in-hospital death, admission to intensive care unit (ICU), and requiring mechanical ventilation. Multivariable Cox regression analysis and Kaplan-Meier plots were used to explore the association between CAC and in-hospital death and adverse clinical outcomes.
Results: The mean age was 50 years (SD,16) and 1097 (53.1%) were male. A total of 177 patients showed high CAC level, and compared with patients with low CAC, these patients were older (mean age: 49 vs. 69 years, P < 0.001) and more likely to be male (52.0% vs. 65.0%, P = 0.001). Comorbidities, including cardiovascular disease (CVD) ([33.3%, 59/177] vs. [4.7%, 89/1890], P < 0.001), presented more often among patients with high CAC, compared with patients with low CAC. As for laboratory results, patients with high CAC had higher rates of increased D-dimer, LDH, as well as CK-MB (all P < 0.05). The mean CT severity score in high CAC group was also higher than low CAC group (12.6 vs. 11.1, P = 0.005). In multivariable Cox regression model, patients with high CAC were at a higher risk of in-hospital death (hazard ratio
, 1.731; 95% CI 1.010-2.971, P = 0.046) and adverse clinical outcomes (HR, 1.611; 95% CL 1.087-2.387, P = 0.018).
Conclusion: High CAC is a risk factor associated with in-hospital death and adverse clinical outcomes in patients with confirmed COVID-19, which highlights the importance of calcium load testing for hospitalized COVID-19 patients and calls for attention to patients with high CAC.
Supplementary information: The online version contains supplementary material available at 10.1007/s42058-021-00072-4.

Keywords: Cardiovascular disease; Coronary artery calcification; Coronavirus disease 2019; Mortality.
 
Back
Top Bottom